Medical Billing for Infectious Disease Physician Services

CO 252 generally indicates that the claim or service was not covered under the patient’s plan or that the payer’s coverage rules did not support payment. The exact explanation should be confirmed against the payer’s remittance advice and accompanying remark code. Review eligibility, benefit classification, authorization, coding, documentation, and whether the service was processed under the medical or pharmacy benefit before deciding whether to correct, resubmit, or appeal.

Common denial categories include services not covered, missing or invalid authorization, eligibility problems, duplicate claims, coding or modifier issues, documentation gaps, timely filing concerns, medical-necessity questions, coordination-of-benefits conflicts, and incorrect medical-versus-pharmacy benefit processing. The code alone is not always enough to identify the fix. The remittance advice, remark code, claim details, payer policy, and clinical documentation should be reviewed together.

Practices can reduce denials by connecting documentation, coding, charge capture, eligibility verification, authorization, and claim review into one workflow. Infectious disease services may involve office visits, hospital consults, infusions, OPAT, and drugs, so each service line should be checked for its applicable payer requirements. Tracking denials by root cause and sharing findings with clinical, coding, and front-office teams can help prevent recurring issues.

Yes. Infectious disease practices may bill physician services alongside infusion administration and drug claims, depending on the services provided and the applicable payer rules. These claims can require careful attention to documentation, units, NDC information, authorization, benefit classification, and charge capture. A billing review should examine how the practice handles each component from acquisition and administration through submission, payment, reconciliation, and follow-up.

Medical and pharmacy benefits can apply different coverage rules, authorization pathways, claim formats, and reimbursement processes. This distinction is especially important for infectious disease infusions, OPAT courses, and specialty drugs. Eligibility and benefit verification should establish how the therapy is handled before services or products are provided. If a claim is processed under the wrong benefit, the practice may need correction, coordination with the payer, or an appeal.

An underpayment review compares the reimbursement received with the amount expected under the applicable payer terms or fee schedule. For infectious disease practices, the review may include drug, administration, E/M, and consult claims, along with units and NDC information where relevant. Findings should be documented by payer and claim type, disputed when appropriate, and tracked through resolution so recurring payment issues can be identified.

Medical billing support may include charge entry, coding review, claim scrubbing, submission, rejection clearing, eligibility and authorization work, denial appeals, payment reconciliation, and aging A/R follow-up. Broader revenue-cycle consulting can also examine referral intake, documentation, drug acquisition, infusion workflows, contracts, and collections. The right scope depends on whether a practice needs overflow assistance, a full workflow review, or help correcting specific revenue leakage.

Yes. A billing and workflow review can examine the path from referral and first dose through authorization, drug acquisition, administration, claim submission, payment, and follow-up. It can also identify gaps affecting whether each site and service is billable, how medical and pharmacy benefits are handled, and where documentation or charge capture may create avoidable delays or unreimbursed costs.